Advertisement

A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women

  • Pattranid Mueangpaisarn
  • Sumapa ChaiamnuayEmail author
Original Article

Abstract

Background

Vitamin D inadequacy is common in institutionalized post-menopausal women who are at the highest risk for osteoporotic fracture.

Aim

To evaluate efficacy and safety of ergocalciferol 40,000 versus 100,000 IU per week for 12 weeks for vitamin D inadequacy in institutionalized postmenopausal women.

Method

A randomized double-blinded placebo-controlled trial was conducted in 94 institutionalized subjects with baseline 25(OH)D levels < 30 ng/mL. Subjects were randomized to receive ergocalciferol 40,000 (standard dose) or ergocalciferol 100,000 IU (high dose) per week. Serum 25(OH)D levels, calcium, phosphate, handgrip strength, time up and go (TUG) test and quality of life by EQ-5D-5L were measured at baseline and 12 weeks after randomization.

Results

Of the 94 subjects enrolled, 85 subjects completed the study. Subjects in the high dose group had higher mean 25(OH)D levels than subjects in the standard group (51.73 ± 19.35 and 34.5 ± 9.12, p < 0.001). More subjects in the high dose group (90.9%) achieved optimal 25(OH)D levels (> 30 ng/mL) than those in the standard group (65.9%), p = 0.007. In a subgroup analysis of subjects with vitamin D deficiency (< 20 ng/mL, n = 44) and severe vitamin D deficiency (< 10 ng/mL, n = 9), more subjects in the high dose group achieved optimal 25(OH)D levels than those in the standard group (88% and 100% versus 47.4% and 16.7% with p of 0.007 and 0.018, respectively). There were no differences in handgrip strength, TUG, EQ-5D-5L and adverse events between groups.

Discussion/conclusions

Subjects who received high dose ergocalciferol achieved more optimal 25(OH)D levels than those who received standard dose. High dose ergocalciferol is preferred to optimize 25(OH)D levels in subjects with severe vitamin D deficiency.

Keywords

Vitamin D Ergocalciferol Postmenopausal women Institutionalized 

Notes

Acknowledgements

The funding from the Phramongkutklao College of Medicine.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study protocol was approved by the Human Subjects Research Committee of the Royal Thai Army Ethic Committee (number 1346/2559) and registered in Thai Clinical Trials Registry: register number TCTR20171122002. All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

All patients voluntarily signed a form indicating their informed consent.

References

  1. 1.
    Meehan M, Penckofer S (2014) The role of vitamin D in the aging adult. J Aging Gerontol 2:60–71CrossRefGoogle Scholar
  2. 2.
    Holick MF (2015) Vitamin D and brain health: the need for vitamin D supplementation and sensible sun exposure. J Intern Med 277:90–93CrossRefGoogle Scholar
  3. 3.
    Grant WB (2015) Using findings from observational studies to guide vitamin D randomized controlled trials. J Intern Med 277:83–86CrossRefGoogle Scholar
  4. 4.
    Christakos S, DeLuca HF (2011) Minireview: vitamin D: is there a role in extraskeletal health? Endocrinology 152:2930–2936CrossRefGoogle Scholar
  5. 5.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281CrossRefGoogle Scholar
  6. 6.
    McCullough ML et al (2010) Correlates of circulating 25-hydroxyvitamin D: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172:21–35CrossRefGoogle Scholar
  7. 7.
    Orwoll E et al (2009) Vitamin D deficiency in older men. J Clin Endocrinol Metab 94:1214–1222CrossRefGoogle Scholar
  8. 8.
    Forrest KY, Stuhldreher WL (2011) Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 31:48–54CrossRefGoogle Scholar
  9. 9.
    American Geriatrics Society Workgroup on Vitamin (2014) D.S.f.O.A., recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc 62:147–152CrossRefGoogle Scholar
  10. 10.
    Lips P et al (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260:245–254CrossRefGoogle Scholar
  11. 11.
    Chailurkit LO, Kruavit A, Rajatanavin R (2011) Vitamin D status and bone health in healthy Thai elderly women. Nutrition 27:160–164CrossRefGoogle Scholar
  12. 12.
    Agrawal S et al (2006) Between-meal risedronate does not alter bone turnover in nursing home residents. J Am Geriatr Soc 54:790–795CrossRefGoogle Scholar
  13. 13.
    Chel V et al (2008) Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19:663–671CrossRefGoogle Scholar
  14. 14.
    Wijnen H et al (2015) Vitamin D supplementation in nursing home patients: randomized controlled trial of standard daily dose versus individualized loading dose regimen. Drugs Aging 32:371–378CrossRefGoogle Scholar
  15. 15.
    Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930CrossRefGoogle Scholar
  16. 16.
    Rizzoli R et al (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 29:305–313CrossRefGoogle Scholar
  17. 17.
    Ross AC et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58CrossRefGoogle Scholar
  18. 18.
    Sansanayudh N et al (2014) Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome. Int J Clin Pharm 36:771–778CrossRefGoogle Scholar
  19. 19.
    Wisit Woranitat KP, Chatkittisilpa S, Jaisamrarn U, Taechakraichana N, What is an appropriate dosage and interval of vitamin D2 supplementation to achieve a sufficiency level in postmenopausal women of Thailand? A randomized, double-blind, placebo-controlled trial. Osteoporos Sarcopenia 2015: 121–126Google Scholar
  20. 20.
    Cruz-Jentoft AJ et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423CrossRefGoogle Scholar
  21. 21.
    Podsiadlo D, Richardson S (1991) The timed “Up and Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148CrossRefGoogle Scholar
  22. 22.
    Pattanaphesaj J et al (2018) The EQ-5D-5L Valuation study in Thailand. Expert Rev Pharmacoecon Outcomes Res 18:551–558CrossRefGoogle Scholar
  23. 23.
    Holick MF et al (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215–3224CrossRefGoogle Scholar
  24. 24.
    Przybelski R et al (2008) Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 19:1621–1628CrossRefGoogle Scholar
  25. 25.
    Mazahery H, Stonehouse W, von Hurst PR (2015) The effect of monthly 50,000 IU or 100,000 IU vitamin D supplements on vitamin D status in premenopausal Middle Eastern women living in Auckland. Eur J Clin Nutr 69:367–372CrossRefGoogle Scholar
  26. 26.
    Dawson-Hughes B et al (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21:1151–1154CrossRefGoogle Scholar
  27. 27.
    Stockton KA et al (2011) Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 22:859–871Google Scholar
  28. 28.
    Visser M et al (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88:5766–5772CrossRefGoogle Scholar
  29. 29.
    Mazahery H, von Hurst PR (2015) Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation. Nutrients 7:5111–5142CrossRefGoogle Scholar
  30. 30.
    Rolland Y et al (2013) Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes. J Nutr Health Aging 17:402–412CrossRefGoogle Scholar
  31. 31.
    Kruavit A et al (2012) Prevalence of vitamin D insufficiency and low bone mineral density in elderly Thai nursing home residents. BMC Geriatr 12:49CrossRefGoogle Scholar
  32. 32.
    Arnljots R et al (2017) Vitamin D deficiency was common among nursing home residents and associated with dementia: a cross sectional study of 545 Swedish nursing home residents. BMC Geriatr 17:229CrossRefGoogle Scholar
  33. 33.
    Sommer I et al (2017) Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-analysis. BMC Geriatr 17:16CrossRefGoogle Scholar
  34. 34.
    Turnbull ER, Drobniewski F (2015) Vitamin D supplementation: a comprehensive review on supplementation for tuberculosis prophylaxis. Expert Rev Respir Med 9:269–275CrossRefGoogle Scholar
  35. 35.
    Campbell AJ, Robertson MC (2010) Comprehensive approach to fall prevention on a national level: New Zealand. Clin Geriatr Med 26:719–731CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Rheumatic Disease Unit, Department of Internal MedicinePhramongkutklao Hospital and Phramongkutklao College of MedicineBangkokThailand

Personalised recommendations